Skip to main content
OpenTrials
Completed

NCT Number: NCT04714840

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

The participants are asked to take part in this clinical trial, a type of research study. The participants are SJLIFE study participants and may have a hard time exercising (exercise intolerance) due to side effects of cancer treatment received as a child.This study is being done to determine if a personalized exercise plan will help childhood cancer survivors who have exercise intolerance become more active.

Primary Objectives:

To achieve the goal of this study, we propose the following three Objectives:

Primary Objective 1:

To determine the efficacy of an individually tailored, home-delivered aerobic and strengthening intervention to improve exercise capacity in survivors of childhood cancer with exercise intolerance (peak oxygen uptake (peak VO2) <85% of age and sex predicted).

Primary Objective 2:

To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on measures of cardiac, pulmonary, musculoskeletal, and neurosensory function in survivors of childhood cancer with exercise intolerance.

Primary Objective 3:

To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on emotional health, participation in family and community activities, quality of life, and cognitive function in survivors of childhood cancer with exercise intolerance.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Childhood Cancer Mobility Limitation Neoplasms Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

About this study

The design for this study will be a single-blind two-arm, prospective, randomized clinical trial. Performance testing results: Both groups of participants will be provided with the results of their performance testing. Individually tailored exercise program: Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist.Generalized exercise recommendations: Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between 18.00 and 39.99 years of age at the time of enrollment
  • SJLIFE participant
  • Peak VO2 <85% predicted
  • Verbalizes understanding of directions for use of ZOOM on the study provided iPad and heart rate monitor
  • Clearance for participation in exercise by a study physician
  • Internet access

Exclusion criteria

  • Enrolled in a formal exercise intervention
  • Self-report of engaging in > 150 minutes/week of moderate physical activity
  • Currently pregnant (assess by urine pregnancy test)
  • Significant psychological distress (e.g. suicidal ideation)
  • Requires immediate medical intervention (e.g. angina, decompensated heart failure)
  • Research Participant Recruitment and Screening

Treatment and study plan

Exercise testing results

Other

Tailored, home-delivered aerobic and strengthening intervention,exercise intolerance,Both groups of participants will be provided with the results of their exercise testing.

Individually tailored exercise program (INT)

Other

Individuals randomized to receive an individually tailored exercise program will meet with an exercise specialist. Written instructions, videos of each strengthening exercise, a blue tooth enable heart rate monitor, all necessary exercise equipment, and an iPad pre-loaded with heart rate monitor software, exercise videos and ZOOM app (for video conferencing) will be provided. After returning home, the exercise specialist will supervise and provide guidance to the individual via the ZOOM app during the first 2 weeks (3 sessions per week). Supervision will slowly decrease to twice a week in weeks 3-4, once a week in weeks 5-8, every other week in weeks 9-16, and to one time midway between weeks 17-20. The exercise program will be adjusted depending on the individuals progress.

Generalized exercise recommendations (AC)

Other

Individuals randomized to receive the generalized exercise recommendations will receive a copy of the Physical Activity Guidelines for Americans. At the baseline visit, a study staff will review these guidelines and answer questions about their exercise testing and encourage them to be physically active. The staff will contact them via telephone to complete a short questionnaire weekly during weeks 1-8 and monthly for weeks 9-20.

Primary outcomes

  1. Exercise Capacity

    Time frame: Baseline to Week 20

    Changes in Peak VO2/2-minute step in place test in both INT and AC groups

  2. Exercise capacity

    Time frame: Week 20 to 6 months after week 20

    Sustainability of changes in Peak VO2/2-minute step in place test in both INT and AC groups

Secondary outcomes

  1. Patient Health Questionnaire (PHQ-9)

    Time frame: baseline, week 20, 6 months after week 20

    Scale: 4 Options - Not at all (minimum value = 0), Several days (1), More than half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-27.

  2. Generalized Anxiety Disorder (GAD-7)

    Time frame: baseline, week 20, 6 months after week 20

    Scale: 5 Options - Not at all sure (minimum value = 0), Several days (1), Over half the days (2), Nearly every day (maximum value = 3). Higher score = worse outcome. Possible score range is 0-21.

  3. PROMIS Ability to Participate 8a (SF v2.0)

    Time frame: baseline, week 20, 6 months after week 20

    Scale: 5 Options - Never (maximum value = 5), Rarely (4), Sometimes (3), Usually (2), Always (minimum value = 1). Higher score = better outcome. Possible score range 8-40.

  4. Work Productivity and Activity Impairment Questionnaire (WPAI)

    Time frame: baseline, week 20, 6 months after week 20

    Scale doesn't apply to overall questionnaire. Outcomes are expressed as impairment percentages. Higher numbers = worse outcome.

  5. Work and Social Adjustment Scale (WSAS)

    Time frame: baseline, week 20, 6 months after week 20

    Scale: 0-8; Not at all (minimum value = 0) to Very Severely (maximum value = 8). Higher score = worse outcome. Possible score range 0-40.

  6. Medical Outcomes Survey Short Form (SF-36)

    Time frame: baseline, week 20, 6 months after week 20

    Consists of 8 scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. Higher score = better outcome.

  7. Childhood Cancer Survivor Study Neurocognitive Questionnaire - Revised (CCSS-NCQ)

    Time frame: baseline, week 20, 6 months after week 20

    Scale: 3 Options - Never a Problem (maximum value = 2), Sometimes a Problem (1) , Often a Problem (minimum value = 0). Higher score = better outcome. Possible score range 0-64.

  8. PROMIS Global Health Short Forms

    Time frame: weekly during the first eight weeks and every four weeks during weeks 9-20

    brief global physical and mental health questionnaires; Scale: 5-point Likert scale, Excellent=5, Poor=1

Sponsors and collaborators

Lead sponsor

St. Jude Children's Research Hospital

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2021
Primary completion
2025
Study completion
2026
First posted
Jan 19, 2021
Registry last updated
Apr 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.